EFFICACY AND SAFETY OUTCOMES UP TO ~4 YEARS OF TREATMENT WITH FILGOTINIB 200 MG AMONG PATIENTS WITH ULCERATIVE COLITIS: RESULTS FROM THE SELECTIONLTE STUDY

Brian G. Feagan  ^{1, 2}     Katsuyoshi Matsuoka  ³     Gerhard Rogler  ⁴     Margaux Faes  ⁵     Angela de Haas  ⁶     Christine Rudolph  ⁶     Laurent Peyrin-Biroulet  ^{7, 8    
1} Alimentiv Inc, London, Canada
² Western University, London, Canada
³ Toho University Sakura Medical Center, Chiba, Japan
⁴ University Hospital Zurich, University of Zurich, Zürich, Switzerland
⁵ Galapagos NV, Mechelen, Belgium
⁶ Galapagos NV, Leiden, Netherlands
⁷ University of Lorraine, Nancy, France
⁸ The Ambroise Paré-Hartmann Private Hospital Group, Paris IBD Centre, Neuilly sur Seine, France

Topic
IBD

Session
Hit the road JAK: Part 2

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)